These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8852700)
1. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7. Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors. Spöhrer U; Thiermann H; Klimmek R; Eyer P Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588 [TBL] [Abstract][Full Text] [Related]
3. HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases. Eyer P; Hagedorn I; Klimmek R; Lippstreu P; Löffler M; Oldiges H; Spöhrer U; Steidl I; Szinicz L; Worek F Arch Toxicol; 1992; 66(9):603-21. PubMed ID: 1482283 [TBL] [Abstract][Full Text] [Related]
4. Effect of atropine and bispyridinium oximes on respiratory and circulatory function in guinea-pigs poisoned by sarin. Worek F; Kirchner T; Szinicz L Toxicology; 1995 Jan; 95(1-3):123-33. PubMed ID: 7825179 [TBL] [Abstract][Full Text] [Related]
5. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine. Clement JG; Bailey DG; Madill HD; Tran LT; Spence JD Biopharm Drug Dispos; 1995 Jul; 16(5):415-25. PubMed ID: 8527690 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector. Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of toxogonin, HI-6 and HLö-7 on the release of [3H]acetylcholine from peripheral cholinergic nerves in rat airway smooth muscle. Aas P Eur J Pharmacol; 1996 Apr; 301(1-3):59-66. PubMed ID: 8773447 [TBL] [Abstract][Full Text] [Related]
8. Trimedoxime and HI-6: kinetic comparison after intravenous administration to mice. Milic B; Maksimovic M; Nedelijkovic M Pharmacol Toxicol; 1996 Apr; 78(4):269-72. PubMed ID: 8861786 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatta): effect of atropine, diazepam, and methoxyflurane anesthesia. Clement JG; Lee MJ; Simons KJ; Briggs CJ Biopharm Drug Dispos; 1990 Apr; 11(3):227-32. PubMed ID: 2328309 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes. RamaRao G; Afley P; Acharya J; Bhattacharya BK BMC Neurosci; 2014 Apr; 15():47. PubMed ID: 24708580 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the oxime HI-6 from a mixture with atropine sulphate in dogs. Jovanović D; Kovacević V; Maksimović M Pharmacol Toxicol; 1992 Nov; 71(5):340-2. PubMed ID: 1448446 [TBL] [Abstract][Full Text] [Related]
12. Effect of poisoning by soman (pinacolyl methylphosphonofluoridate) on the serum half-life of the cholinesterase reactivator HI-6 in mice. Clement JG; Simons KJ; Briggs CJ Biopharm Drug Dispos; 1988; 9(2):177-86. PubMed ID: 3370306 [TBL] [Abstract][Full Text] [Related]
14. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration. Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys. Busker RW; Zijlstra JJ; Philippens IH; Groen B; Melchers BP Toxicology; 1996 Sep; 112(3):183-94. PubMed ID: 8845039 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats. van Helden HP; van der Wiel HJ; Zijlstra JJ; Melchers BP; Busker RW Arch Toxicol; 1994; 68(4):224-30. PubMed ID: 8067894 [TBL] [Abstract][Full Text] [Related]
17. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration. Lukey BJ; Woodard CL; Clark CR; McCluskey MP J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice. Clement JG; Shiloff JD; Gennings C Arch Toxicol; 1987; 61(1):70-5. PubMed ID: 3326546 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability and disposition kinetics of HI-6 in Beagle dogs. Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028 [TBL] [Abstract][Full Text] [Related]
20. Atropine and oxime treatment in lethal soman poisoning of anaesthetized guinea-pigs: HLö 7 dimethanesulfonate versus HI 6 dichloride. Worek F; Szinicz L Pharmacol Toxicol; 1993 Jan; 72(1):13-21. PubMed ID: 8441735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]